Haleon plc (LON:HLN) Insider Acquires £86,265 in Stock

Haleon plc (LON:HLN - Get Free Report) insider Marie-Anne Aymerich purchased 21,300 shares of the company's stock in a transaction that occurred on Friday, May 9th. The shares were acquired at an average cost of GBX 405 ($5.34) per share, with a total value of £86,265 ($113,656.13).

Haleon Stock Down 1.3%

Shares of LON:HLN opened at GBX 398.60 ($5.25) on Tuesday. The firm has a market cap of £35.98 billion, a P/E ratio of 33.52, a P/E/G ratio of 1.49 and a beta of 0.19. Haleon plc has a 12-month low of GBX 319.84 ($4.21) and a 12-month high of GBX 417.70 ($5.50). The business has a fifty day simple moving average of GBX 385.73 and a 200 day simple moving average of GBX 380.63. The company has a quick ratio of 0.93, a current ratio of 0.84 and a debt-to-equity ratio of 53.36.

Haleon (LON:HLN - Get Free Report) last issued its quarterly earnings data on Friday, February 28th. The company reported GBX 15.80 ($0.21) earnings per share (EPS) for the quarter. Haleon had a net margin of 9.66% and a return on equity of 6.54%. Analysts predict that Haleon plc will post 19.5033282 earnings per share for the current year.

Haleon Increases Dividend

The company also recently declared a dividend, which will be paid on Thursday, June 5th. Investors of record on Thursday, April 24th will be issued a dividend of GBX 4.60 ($0.06) per share. This is a positive change from Haleon's previous dividend of $2.00. This represents a yield of 1.18%. The ex-dividend date of this dividend is Thursday, April 24th. Haleon's dividend payout ratio is currently 50.46%.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank boosted their price objective on shares of Haleon from GBX 456 ($6.01) to GBX 457 ($6.02) and gave the stock a "buy" rating in a research note on Friday, February 28th.

Haleon Company Profile

Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.